OMNIBRX

About OMNIBRX

OmniBRx Biotechnologies strives to revolutionize the quality, scalability, and predictability of biologics manufacturing, including vaccines, monoclonal antibodies (MAbs), and therapeutic mammalian protein production. We are a biotech company specifically focused on upstream bioprocessing solutions. We have entered the bioprocessing market with the most advanced, efficient, and scalable CellBRx range of bioreactors for adherent cell culture bioprocessing. We are ready to serve as a trusted partner to global biopharmaceutical companies, helping to develop and manufacture game-changing bioprocessing solutions. We manufacture automated single-use perfusion bioreactor systems and provide custom services for GMP production, from pre-clinical to commercial scale, in quantities ranging from mg to kg.